A detailed history of Marshall Wace, LLP transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Marshall Wace, LLP holds 982,048 shares of CLBT stock, worth $16.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
982,048
Previous 1,235,143 20.49%
Holding current value
$16.9 Million
Previous $13.7 Million 14.25%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$10.38 - $12.5 $2.63 Million - $3.16 Million
-253,095 Reduced 20.49%
982,048 $11.7 Million
Q1 2024

May 15, 2024

BUY
$8.04 - $12.29 $2.7 Million - $4.13 Million
336,286 Added 37.41%
1,235,143 $13.7 Million
Q4 2023

Feb 14, 2024

BUY
$6.45 - $8.76 $2.59 Million - $3.52 Million
401,454 Added 80.71%
898,857 $7.78 Million
Q3 2023

Nov 14, 2023

BUY
$6.86 - $8.18 $3.15 Million - $3.75 Million
458,889 Added 1191.49%
497,403 $3.81 Million
Q2 2023

Aug 14, 2023

BUY
$5.3 - $7.2 $204,124 - $277,300
38,514 New
38,514 $277,000

Others Institutions Holding CLBT

About Cellebrite DI Ltd.


  • Ticker CLBT
  • Exchange NASDAQ
  • Sector Technology
  • Industry Software—Infrastructure
  • Shares Outstandng 189,648,992
  • Market Cap $3.27B
  • Description
  • Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...
More about CLBT
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.